Pain & Inflammation Therapy

About Electrome

Electrome is positioning itself as a category leader in the emerging field of bioelectric medicine. Its core strategy involves an integrated platform combining a proprietary AI-powered discovery engine, a bioelectric data knowledge graph, and a modular hardware system to rapidly develop and commercialize non-invasive electroceuticals. With a first therapy for pain and inflammation prepared for launch via a 510(k) regulatory path, the company aims for near-term revenue while building a pipeline across high-burden diseases like wound healing, infectious disease, and oncology.

Therapeutic Areas

Other Pain and Inflammation Drugs